Infectious Diseases (except HIV/AIDS)

  1. T cell responses to SARS-CoV-2 spike cross-recognize Omicron

    1. Roanne Keeton
    2. Marius B. Tincho
    3. Amkele Ngomti
    4. Richard Baguma
    5. Ntombi Benede
    6. Akiko Suzuki
    7. Khadija Khan
    8. Sandile Cele
    9. Mallory Bernstein
    10. Farina Karim
    11. Sharon V. Madzorera
    12. Thandeka Moyo-Gwete
    13. Mathilda Mennen
    14. Sango Skelem
    15. Marguerite Adriaanse
    16. Daniel Mutithu
    17. Olukayode Aremu
    18. Cari Stek
    19. Elsa du Bruyn
    20. Mieke A. Van Der Mescht
    21. Zelda de Beer
    22. Talita R. de Villiers
    23. Annie Bodenstein
    24. Gretha van den Berg
    25. Adriano Mendes
    26. Amy Strydom
    27. Marietjie Venter
    28. Jennifer Giandhari
    29. Yeshnee Naidoo
    30. Sureshnee Pillay
    31. Houriiyah Tegally
    32. Alba Grifoni
    33. Daniela Weiskopf
    34. Alessandro Sette
    35. Robert J. Wilkinson
    36. Tulio de Oliveira
    37. Linda-Gail Bekker
    38. Glenda Gray
    39. Veronica Ueckermann
    40. Theresa Rossouw
    41. Michael T. Boswell
    42. Jinal N. Bhiman
    43. Penny L. Moore
    44. Alex Sigal
    45. Ntobeko A. B. Ntusi
    46. Wendy A. Burgers
    47. Catherine Riou

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. National Scale Real-Time Surveillance of SARS-CoV-2 Variants Dynamics by Wastewater Monitoring in Israel

    1. Itay Bar-Or
    2. Victoria Indenbaum
    3. Merav Weil
    4. Michal Elul
    5. Nofar Levi
    6. Irina Aguvaev
    7. Zvi Cohen
    8. Virginia Levy
    9. Roberto Azar
    10. Batya Mannasse
    11. Rachel Shirazi
    12. Efrat Bucris
    13. Orna Mor
    14. Alin Sela Brown
    15. Danit Sofer
    16. Neta S. Zuckerman
    17. Ella Mendelson
    18. Oran Erster

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Reliably Assessing Duration of Protection for Coronavirus Disease 2019 Vaccines

    1. Dan-Yu Lin
    2. Donglin Zeng
    3. Yu Gu
    4. Philip R Krause
    5. Thomas R Fleming

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

    1. Thiago Cerqueira-Silva
    2. Jason R Andrews
    3. Viviane S Boaventura
    4. Otavio T Ranzani
    5. Vinicius de Araújo Oliveira
    6. Enny S Paixão
    7. Juracy Bertoldo Júnior
    8. Tales Mota Machado
    9. Matt D T Hitchings
    10. Murilo Dorion
    11. Margaret L Lind
    12. Gerson O Penna
    13. Derek A T Cummings
    14. Natalie E Dean
    15. Guilherme Loureiro Werneck
    16. Neil Pearce
    17. Mauricio L Barreto
    18. Albert I Ko
    19. Julio Croda
    20. Manoel Barral-Netto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19

    1. Georg M. N. Behrens
    2. Joana Barros-Martins
    3. Anne Cossmann
    4. Gema Morillas Ramos
    5. Metodi V. Stankov
    6. Ivan Odak
    7. Alexandra Dopfer-Jablonka
    8. Laura Hetzel
    9. Miriam Köhler
    10. Gwendolyn Patzer
    11. Christoph Binz
    12. Christiane Ritter
    13. Michaela Friedrichsen
    14. Christian Schultze-Florey
    15. Inga Ravens
    16. Stefanie Willenzon
    17. Anja Bubke
    18. Jasmin Ristenpart
    19. Anika Janssen
    20. George Ssebyatika
    21. Verena Krähling
    22. Günter Bernhardt
    23. Markus Hoffmann
    24. Stefan Pöhlmann
    25. Thomas Krey
    26. Berislav Bošnjak
    27. Swantje I. Hammerschmidt
    28. Reinhold Förster

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?

    1. Wataru Ogura
    2. Kouki Ohtsuka
    3. Sachiko Matsuura
    4. Takahiro Okuyama
    5. Satsuki Matsushima
    6. Satoko Yamasaki
    7. Hiroyuki Miyagi
    8. Kumiko Sekiguchi
    9. Hiroaki Ohnishi
    10. Takashi Watanabe

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2 seroprevalence at urban and rural sites in Kaduna State, Nigeria, during October/November 2021, immediately prior to detection of the Omicron variant

    1. Gloria D Chechet
    2. Jacob K P Kwaga
    3. Joseph Yahaya
    4. Harry Noyes
    5. Annette MacLeod
    6. Walt E Adamson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Risk of myopericarditis following COVID ‐19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods

    1. Katie A. Sharff
    2. David M. Dancoes
    3. Jodi L. Longueil
    4. Eric S. Johnson
    5. Paul F. Lewis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Transmission of SARS-CoV-2 among children and staff in German daycare centres

    1. Julika Loss
    2. Juliane Wurm
    3. Gianni Varnaccia
    4. Anja Schienkiewitz
    5. Helena Iwanowski
    6. Anne-Kathrin Mareike Loer
    7. Jennifer Allen
    8. Barbara Wess
    9. Angelika Schaffrath Rosario
    10. Stefan Damerow
    11. Tim Kuttig
    12. Hanna Perlitz
    13. Anselm Hornbacher
    14. Bianca Finkel
    15. Carolin Krause
    16. Jan Wormsbächer
    17. Anna Sandoni
    18. Ulrike Kubisch
    19. Kiara Eggers
    20. Andreas Nitsche
    21. Aleksandar Radonic
    22. Kathrin Trappe
    23. Oliver Drechsel
    24. Kathleen Klaper
    25. Andrea Franke
    26. Antje Hüther
    27. Udo Buchholz
    28. Walter Haas
    29. Lothar H. Wieler
    30. Susanne Jordan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects

    1. Jasper de Boer
    2. Ursula Saade
    3. Elodie Granjon
    4. Sophie Trouillet-Assant
    5. Carla Saade
    6. Hans Pottel
    7. Maan Zrein
    8. Covid ser study group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 237 of 716 Next